🎓 Expert Commentary / Peer Perspective
Sedative-hypnotics remain widely used for insomnia, but prescribing often extends beyond populations studied in trials. This expert review outlines practical considerations for drug selection, dosing, and timing, particularly in patients with psychiatric comorbidities.
Clinical Considerations
- Sleep-onset and sleep-maintenance insomnia require different pharmacologic strategies, with drug selection guided by onset time and half-life.
- Food intake and gastric emptying significantly alter hypnotic absorption, delaying onset and reducing effectiveness in sleep-onset insomnia.
- CYP3A4 interactions with hypnotics may alter drug exposure, requiring dose adjustments in patients on enzyme inducers or inhibitors.
- Excess sedation from psychotropics can be mitigated through dose timing, split dosing, or cautious stimulant use, accounting for interaction risks.
Practice Applications
- Consider matching hypnotic choice to sleep-onset versus maintenance patterns.
- Recognize meal timing as a modifiable factor in hypnotic effectiveness.
- Monitor for metabolic drug interactions affecting sedation duration.
- Adjust dosing schedules to reduce oversedation without reducing therapeutic dose.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS